• Sur l'apolipoprotéine D 

SARJEANT, J., LAURIE, A., KINNEAR, C., YABLONSKY, S., LEUNG, W., MASSAELI, H., PRICHETT, W., VEINOT, JP., RASSART, E., and RABINOVITCH, M. 2003. Apolipoprotein D inhibits PDGF-induced vascular smooth muscle cell proliferation by preventing tranlocation of P-ERK1/2 to the nucleus. Arteriosclerosis, Thrombosis and Vascular Biology, 23 : 2172-2177

LEUNG, W., LAURIE, A., DEMARIES, S., MASSAELLI. H., BURRY, A., YABLONSKY, S., SARJEANT, J., FERA, E., RASSART, E., PICKERING, G. and RABINOVITCH, M. 2004. Apolipoprotein D enhances PDGF BB dependent vascular smooth muscle cell migration. Circulation Research 95: 179-186.

VAN DIJK, W., DO CARMO, S., RASSART, E., DAHLBÄCK, B., and SODETZ, J.M.2006. The plasma lipocalins a₁-acid glycoprotein, apolipoprotein D, apolipoprotein M and complement component C8?. LIPOCALINS. Landes Bioscience/Eurekah. Georgetown, Texas, USA. Edited by Akerström, B., Borregaard, N., Flower, D and Salier, J-P. sous presse

DO CARMO, S., SEGUIN, D., MILNE, R., RASSAT, E. 2002. Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem. 15;277(7):5514-23.

TERRISSE, L., MARCOUX, K., DO CARMO, S., BRISSETTE, L., MILNE, R., RASSART, E. 2001. Structure-function relationships of human apolipoprotein D an immunochemical analysis. Life Sci. 28;70(6):629-38.

RASSART, E., BEDIRIAN, A., DO CARMO, S., GUINARD, O., SIROIS, J., TERRISSE, L., and MILNE, R. 2000. Apolipoprotein D. Biochim Biophys Acta. 18;1482(1-2):185-98. Review.

TERRISSE, L., SÉGUIN, D., BERTRAND, P., POIRIER, J., MILNE, R., and RASSART, E. 1999. Modulation of Apolipoprotein D and apolipoprotein E mRNA expression in rat hippocampus after enthorinal cortex lesion. Molecular Brain Research, 70: 26-35

TERRISSE,L., POIRIER, J., BERTRAND, P., MERCHED, A., SIEST, G., MILNE, R., and RASSART, E. 1998. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J. of Neurochemistry, 71: 1643-1650.

• Sur les rétrovirus murins

  VOISIN, V., BARAT, C., HOANG, T. and RASSART, E. 2006. Novel insights into the pathogenesis of the murine leukemia retrovirus Graffi. J. of Virology. 80: 4026-4037.

  LANDAIS, S., QUANTIN, R. and RASSART, E. 2005. RadLV common integration at the Kis2 locus : simultaneous overexpression of a novel non-coding RNA and of the proximal PHF6 gene. J. of Virology. 79: 11443-11456.

  DANIS, C., DESCHAMBEAULT, J., DO CARMO, S., COHEN, E.A., RASSART, E. and LEMAY, G. 2004. The Tyrosine-Based YXXO Targeting Motif of Murine Leukemia Virus Envelope Glycoprotein affects pathogenesis. Virology 324: 173-183.

  DENICOURT, C., KOZAK, CA., and RASSART, E. 2003. Gris1, a new common integration site in Graffi murine leukemia virus-induced leukemias: overexpression of a truncated cyclin D2 due to alternative splicing. J Virol 77:37-44.

  BARAT C., BARBEAU B., DELATTRE O., and RASSART E. 2000. Presence of new alternative exons in human and mouse Fli-1 genes. Biochim. Biophys. Acta 1517 : 164-170.

  LAMBERT, J., BERGERON, D., KOZAK, C., and RASSART, E. 1999. Identification of a common site of provirus integration in Radiation Leukemia Virus induced T-cell lymphomas. Virology, 264 : 181-186.

  BARBEAU,B., BARAT, C., BERGERON, D., and RASSART, E. 1999. The GATA-1 and SPI-1 transcriptional factors bind to an EBS/GATA dual element in the Fli-1 exon 1. Oncogene,18: 5535-5545

  DENICOURT, C., EDOUARD, E., and RASSART, E. 1999. Oncogene activation in myeloid leukemias by Graffi MuLV proviral integration. J. Virology. 73: 4439-4442.